# Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

> **NCT02445404** · PHASE2 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 134 (estimated)

## Conditions studied

- Peripheral T-cell Lymphoma

## Interventions

- **DRUG:** CHOP
- **DRUG:** fractionated ICED

## Key facts

- **NCT ID:** NCT02445404
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09-23
- **Primary completion:** 2022-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02445404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02445404, "Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02445404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*